Site last updated:
December 2011
Cancer Services Forum currently has 1452 registered members
New cancer medicines: Joint working between the NHS and the pharmaceutical industry
Share
Steve Williamson, Conference Chair and Consultant Pharmacist for Cancer Services
Introduction
A bright and crisp November morning in Newcastle saw the first national conference to be held by the North of England Cancer Drugs Approval Group (NECDAG). The theme of the conference was joint working between the National Health Service (NHS) and the pharmaceutical industry and how the two might work together to optimise access to cancer medicines for NHS patients.
Delegates included representatives from both camps, each understanding that there was a lot to learn from the other. How can we work effectively together, for example, until the NHS understands fully how the pharmaceutical industry tackles oncology drug pricing and marketing in the UK and, in turn, the pharmaceutical industry has an in-depth understanding of the constraints under which the NHS commissions cancer drugs?
Page 1 of 14
Discussion.